Next-Gen flu shot: can mRNA tech beat the seasonal bug?
NCT ID NCT07121192
Summary
This study is testing new flu vaccines made with mRNA technology, similar to some COVID-19 shots. It aims to see how well they trigger an immune response and how safe they are in healthy adults aged 18 and older. The trial is comparing different versions of the vaccine to gather this information.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for INFLUENZA, HUMAN are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
GSK Investigational Site
Anniston, Alabama, 36207, United States
-
GSK Investigational Site
Fair Oaks, California, 95628, United States
-
GSK Investigational Site
San Diego, California, 92120, United States
-
GSK Investigational Site
San Diego, California, 92123, United States
-
GSK Investigational Site
Walnut Creek, California, 94598, United States
-
GSK Investigational Site
Hialeah, Florida, 33012, United States
-
GSK Investigational Site
Jupiter, Florida, 33458, United States
-
GSK Investigational Site
Miami, Florida, 33186, United States
-
GSK Investigational Site
Atlanta, Georgia, 30281, United States
-
GSK Investigational Site
Valparaiso, Indiana, 46383, United States
-
GSK Investigational Site
Lenexa, Kansas, 66219, United States
-
GSK Investigational Site
Springfield, Massachusetts, 01103, United States
-
GSK Investigational Site
Carson City, Nevada, 89706, United States
-
GSK Investigational Site
Rochester, New York, 14609, United States
-
GSK Investigational Site
Greensboro, North Carolina, 27408, United States
-
GSK Investigational Site
Cleveland, Ohio, 44122, United States
-
GSK Investigational Site
North Charleston, South Carolina, 29405, United States
-
GSK Investigational Site
Austin, Texas, 78705, United States
-
GSK Investigational Site
DeSoto, Texas, 75115, United States
-
GSK Investigational Site
Fort Worth, Texas, 76135, United States
-
GSK Investigational Site
Newport News, Virginia, 23606, United States
-
GSK Investigational Site
Seattle, Washington, 98104, United States
Conditions
Explore the condition pages connected to this study.